Error: Could not add to watchlist. X
+ Watchlist

InterMune Inc

ITMN:US
Acquired
ITMN:US was acquired by 115796Z:US
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.57
Market Cap (USD)
-
Shares Outstanding (m)
107.969
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.11%
% Price Change
+0.41%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
InterMune, Inc. is a biotechnology company. The Company focuses on the research, development and commercialization of therapies in pulmonology and fibrotic diseases. InterMune operates in North America.
Address
3280 Bayshore Blvd
Brisbane, CA 94005
United States
Phone
1-415-466-2200
Show More